Pliner, Leonid https://orcid.org/0000-0001-5823-3868
Laneret, Nathan
Roudaut, Meryl https://orcid.org/0000-0003-2373-7593
Mogrovejo-Valdivia, Alejandra https://orcid.org/0000-0002-1532-6631
Vandenhaute, Elodie
Maubon, Nathalie
Toillon, Robert-Alain https://orcid.org/0000-0001-5483-2118
Karrout, Youness
Treizebre, Anthony https://orcid.org/0000-0002-2265-8095
Annicotte, Jean-Sébastien https://orcid.org/0000-0002-2109-4849
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (I-SITE ULNE/ ANR-16-IDEX-0004 ULNE)
Article History
Received: 7 June 2024
Revised: 27 September 2024
Accepted: 30 September 2024
First Online: 25 October 2024
Declarations
:
: M.R., A.M.V., E.V., and N.M. are board members and/or employees of HCS Pharma, which provided BIOMIMESYS® scaffold. N.M. owns stocks in HCS Pharma. The other authors have no relevant financial or non-financial interests to disclose.